CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase I Study of Chimeric Antigen Receptor Modified T Cells in Patients With Mesothelin Expressing Cancers
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02159716
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:38.512030+00:00
- Published At
- 2025-06-29T00:00:00+00:00
- Record Updated At
- 2025-06-29
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Metastatic Pancreatic (Ductal) Adenocarcinoma", "Epithelial Ovarian Cancer", "Malignant Epithelial Pleural Mesothelioma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-06-29"- protocolSection.identificationModule.nctId
"NCT02159716"- protocolSection.identificationModule.officialTitle
"Phase I Study of Chimeric Antigen Receptor Modified T Cells in Patients With Mesothelin Expressing Cancers"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.